0000950123-05-002682.txt : 20120626 0000950123-05-002682.hdr.sgml : 20120626 20050307083917 ACCESSION NUMBER: 0000950123-05-002682 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20050307 DATE AS OF CHANGE: 20050307 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: METLIFE INC CENTRAL INDEX KEY: 0001099219 STANDARD INDUSTRIAL CLASSIFICATION: INSURANCE AGENTS BROKERS & SERVICES [6411] IRS NUMBER: 134075851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-58857 FILM NUMBER: 05662775 BUSINESS ADDRESS: STREET 1: 200 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10166 BUSINESS PHONE: 2125782211 MAIL ADDRESS: STREET 1: 200 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10166 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BOARD OF DIRECTORS OF METLIFE INC CENTRAL INDEX KEY: 0001111726 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: ONE MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10010-3690 BUSINESS PHONE: 2125782211 MAIL ADDRESS: STREET 1: ONE MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10010-3690 SC 13D/A 1 y06277sc13dza.txt AMENDMENT #20 TO SCHEDULE 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 20 TO SCHEDULE 13D Under the Securities Exchange Act of 1934 MetLife, Inc. (Name of Issuer) Common Stock, par value $.01 per share (Title of Class of Securities) 59156R108 (CUSIP Number) James L. Lipscomb, Esq. Executive Vice-President and General Counsel MetLife, Inc. 200 Park Avenue New York, NY 10166-0188 (212) 578-2211 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) March 7, 2005 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box [ ]. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 10 Pages SCHEDULE 13D CUSIP No. 59156R108 Page 2 of 10 Pages -------------------------------------------------------------------------------- (1) Names of Reporting Persons Board of Directors of MetLife, Inc., as an entity I.R.S. Identification Nos. of Above Persons Not applicable -------------------------------------------------------------------------------- (2) Check the Appropriate Box (a) [ ] if a Member of a Group (b) [ ] -------------------------------------------------------------------------------- (3) SEC Use Only -------------------------------------------------------------------------------- (4) Source of Funds Not Applicable. See Item 4 -------------------------------------------------------------------------------- (5) Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) [ ] -------------------------------------------------------------------------------- (6) Citizenship or Place of Organization U.S.A. -------------------------------------------------------------------------------- Number of Shares (7) Sole Voting Power 0 Beneficially Owned by Each Reporting -------------------------------------------------------- Person With (8) Shared Voting Power 317,387,457* -------------------------------------------------------- (9) Sole Dispositive Power 0 -------------------------------------------------------- (10) Shared Dispositive Power 0 -------------------------------------------------------------------------------- (11) Aggregate Amount Beneficially Owned by Each Reporting Person 317,387,457 -------------------------------------------------------------------------------- (12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares [ ] -------------------------------------------------------------------------------- (13) Percent of Class Represented by Amount in Row 11 43.2% -------------------------------------------------------------------------------- (14) Type of Reporting Person OO -------------------------------------------------------------------------------- * Unless otherwise indicated, all information relating to beneficial ownership of the Shares by the Reporting Persons is as of February 28, 2005. SCHEDULE 13D CUSIP No. 59156R108 Page 3 of 10 Pages Items 4 and 5 are amended as set forth below: ITEM 4. PURPOSE OF TRANSACTION. The Board of Directors is reporting beneficial ownership of 317,387,457 shares of Common Stock (the "Shares") held by the MetLife Policyholder Trust (the "Trust") under the Plan of Reorganization, dated September 28, 1999, as amended (the "Plan"), of Metropolitan Life Insurance Company ("MetLife"). On April 7, 2000, 494,466,664 Shares were issued to the Trust pursuant to Section 5.2(d) of the Plan, a copy of which is filed as an exhibit to this statement. No consideration has been separately provided therefor by any member of the Board of Directors, except for Shares allocated to such member pursuant to the Plan. Since April 7, 2000, transactions by Beneficiaries under the Purchase and Sale Program provided for by the Trust Agreement (as defined below) have resulted in a decrease in the number of Shares held by the Trust from 494,466,664 to 317,387,457 (as adjusted to reflect refinements in the calculation of the number of Shares issued to the Trust under the Plan). Under the Plan and the MetLife Policyholder Trust Agreement, dated as of November 3, 1999 (as amended, the "Trust Agreement"), by and among MetLife, the Issuer, Wilmington Trust Company (the "Trustee") and ChaseMellon Shareholder Services, L.L.C., as custodian (now known as Mellon Investor Services LLC, the "Custodian"), a copy of which is attached as an exhibit to this statement, certain eligible policyholders of MetLife ("Trust Eligible Policyholders") have been allocated a number of interests in the Trust ("Trust Interests") equal to the number of shares of Common Stock allocated to the Trust Eligible Policyholders in accordance with the Plan. The assets of the Trust principally are the Shares issued to the Trust for the benefit of the Trust Eligible Policyholders and permitted transferees (collectively, the "Beneficiaries"). The Shares are held in the name of the Trustee, on behalf of the Trust, which has legal title over the Shares. The Beneficiaries do not have legal title to any part of the assets of the Trust. The Trust Interests represent undivided fractional interests in the Shares and other assets of the Trust beneficially owned by a Trust Beneficiary through the Custodian. The Trust Agreement provides the Trustee with directions as to the manner in which to vote, assent or consent the Shares at all times during the term of the Trust. On all matters brought for a vote before the stockholders of the Issuer, with the exception of a Beneficiary Consent Matter (as defined below), the Trustee will vote in accordance with the SCHEDULE 13D CUSIP No. 59156R108 Page 4 of 10 Pages recommendation given by the Board of Directors of the Issuer to its stockholders or, if no such recommendation is given, as directed by the Board. On all Beneficiary Consent Matters, the Trustee will vote all of the Shares in favor of, in opposition to or abstain from the matter in the same ratio as the Trust Interests of the Beneficiaries that returned voting instructions to the Trustee indicated preferences for voting in favor of, in opposition to or abstaining from such matter. The Trust Agreement also contains provisions allowing Beneficiaries to instruct the Custodian to withdraw their allocated Trust Shares to participate in any tender or exchange offer for the Common Stock and to make any cash or share election, or perfect any dissenter's rights, in connection with a merger of the Issuer. A "Beneficiary Consent Matter" is: (i) a contested election of directors or, subject to certain conditions, the removal of a director, (ii) a merger or consolidation, a sale, lease or exchange of all or substantially all of the assets or a recapitalization or dissolution of the Issuer, if it requires a vote of stockholders under applicable Delaware law, (iii) any transaction that would result in an exchange or conversion of the Shares for cash, securities or other property, (iv) issuances of Common Stock prior to the first anniversary of the effective date of the Plan (the "Effective Date") at a price materially below the prevailing market price, if a vote is required to approve the issuance under Delaware law, other than issuances in an underwritten public offering or pursuant to an employee benefit plan, (v) before the first anniversary of the Effective Date, any matter that requires approval by a vote of more than a majority of the outstanding stock of the Issuer entitled to vote thereon under Delaware law or the certificate of incorporation or the by-laws of the Issuer, and any amendment to the certificate of incorporation or by-laws of the Issuer that is submitted to a vote of stockholders for approval, and (vi) proposals submitted to stockholders requiring the Board of Directors to amend the Issuer's Stockholder Rights Plan, or redeem rights under that plan, other than a proposal with respect to which the Issuer has received advice of nationally-recognized legal counsel to the effect that the proposal is not a proper subject for stockholder action under Delaware law. The Trust Agreement contains provisions enabling the Beneficiaries to withdraw the Shares allocated to them under the Plan and the Trust Agreement for resale or otherwise and to receive dividends on such Shares. SCHEDULE 13D CUSIP No. 59156R108 Page 5 of 10 Pages ITEM 5. INTEREST IN SECURITIES OF THE ISSUER. (a) As an entity, the Board of Directors of the Issuer beneficially owns 317,387,457 shares or 43.2% of the Issuer's outstanding Common Stock. The Board of Directors of the Issuer is deemed to beneficially own the shares of Common Stock held by the Trust because the Board will direct the voting of these shares on certain matters submitted to a vote of stockholders. See Item 4. (b) As an entity, the Board of Directors of the Issuer has shared voting power with respect to 317,387,457 shares of Common Stock. (c) Except as described in Item 4, there were no transactions in the class of securities reported on that were effected by the Reporting Persons since October 31, 2004 other than transactions by Beneficiaries under the Purchase and Sale Program provided for by the Trust Agreement, resulting in a decrease in the number of shares of Common Stock held by the Trust from 324,080,296 to 317,387,457. (d) The Beneficiaries of the Trust have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Shares allocated to them under the Plan and the Trust Agreement. See Item 4. SCHEDULE 13D CUSIP No. 59156R108 Page 6 of 10 Pages SIGNATURES. After reasonable inquiry and to the best of my knowledge and belief, we certify that the information set forth in this statement is true, complete and correct. Dated: March 7, 2005 * ------------------------------ Curtis H. Barnette * ------------------------------ Robert H. Benmosche * ------------------------------ Burton A. Dole, Jr. * ------------------------------ Cheryl W. Grise * ------------------------------ James R. Houghton * ------------------------------ Harry P. Kamen * ------------------------------ Helene L. Kaplan * ------------------------------ John M. Keane * ------------------------------ James M. Kilts * ------------------------------ Charles M. Leighton * ------------------------------ Sylvia M. Mathews SCHEDULE 13D CUSIP No. 59156R108 Page 7 of 10 Pages * ------------------------------ Hugh B. Price * ------------------------------ Kenton J. Sicchitano * ------------------------------ William C. Steere, Jr. * By /s/ Gwenn L. Carr ------------------------------- Gwenn L. Carr Attorney-in-fact EX-99.1 2 y06277exv99w1.txt JOINT FILING AGREEMENT SCHEDULE 13D CUSIP No. 59156R108 Page 8 of 10 Pages Exhibit 1 JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1)(iii) promulgated under the Securities Exchange Act of 1934, as amended, each of the undersigned agrees that the Statement on Amendment No. 20 to Schedule 13D, to which this exhibit is attached, is filed on his or her behalf. Dated: March 7, 2005 * ------------------------------ Curtis H. Barnette * ------------------------------ Robert H. Benmosche * ------------------------------ Burton A. Dole, Jr. * ------------------------------ Cheryl W. Grise * ------------------------------ James R. Houghton * ------------------------------ Harry P. Kamen * ------------------------------ Helene L. Kaplan * ------------------------------ John M. Keane * ------------------------------ James M. Kilts * ------------------------------ Charles M. Leighton * ------------------------------ Sylvia M. Mathews SCHEDULE 13D CUSIP No. 59156R108 Page 9 of 10 Pages * ------------------------------ Hugh B. Price * ------------------------------ Kenton J. Sicchitano * ------------------------------ William C. Steere, Jr. * By /s/ Gwenn L. Carr ----------------------------- Gwenn L. Carr Attorney-in-fact EX-99.2 3 y06277exv99w2.txt POWER OF ATTORNEY SCHEDULE 13D CUSIP No. 59156R108 Page 10 of 10 Pages Exhibit 2 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that the undersigned hereby constitutes and appoints Gwenn L. Carr the undersigned's true and lawful attorney-in-fact, with full power of substitution and resubstitution, for the undersigned and in the undersigned's name, place and stead, in any and all capacities, to sign amendments to a Schedule 13D with regard to the MetLife, Inc. Board of Directors' ownership of securities of MetLife, Inc. ("Schedule 13D"), and to file the same, with exhibits thereto and other documents related thereto, with the Securities and Exchange Commission, hereby ratifying and confirming all that said attorney-in-fact or her substitute or substitutes may do or cause to be done by virtue hereof. The authority of Gwenn L. Carr under this Power of Attorney shall continue until the Board of Directors is no longer required to file amendments to the Schedule 13D, unless earlier revoked in writing by the undersigned. Dated: March 3, 2005 /s/ James M. Kilts ------------------------ James M. Kilts